1'758 companies found
Vaccine Formulation Institute SA
Plan-Les-Ouates · Since 2020
The core activity of Vaccine Formulation Institute (VFI) is the development and provision of adjuvants and vaccine formulations for global health. The company supports the vaccine community by providing adjuvants and formulation expertise, supports the development of adjuvanted vaccines up to industrial scale, and helps donors and funders implement vaccine development programs.
Integrum Medical AG
Birmensdorf Zh · Since 2017
Ayus Medical Devices AG
Steinhausen · Since 2023
Ironwood Pharmaceuticals GmbH
Basel · Since 2012
The core activity of Ironwood is the development and manufacture of pharmaceutical products, particularly the research and development of therapeutics for various diseases and health conditions.
Isle of Youth AG
Sarnen · Since 2021
Jamila Therapeutics AG
Walchwil · Since 2020
The core activity of Jamila Therapeutics is to improve and expand access to proven and life-saving medicines for patients worldwide by extending the shelf life of critical therapies and providing sustainable healthcare, while addressing the social and logistical challenges in healthcare.
KeyBioscience SA
Lugano · Since 2012
KeyBioscience SA is a biotechnology company focused on the discovery and development of fully human monoclonal antibodies for the prevention and treatment of serious bacterial and viral infections in the hospital setting. It applies the MabIgX® technology to generate and select fully human monoclonal antibodies and is developing candidates such as KBRV201 targeting respiratory syncytial virus (RSV).
Khelma AG
Zug · Since 2024
Khelma AG develops science‑based dietary supplements and a Healthy Aging & Longevity platform whose formulations are designed to target multiple biological mechanisms of aging. The company offers products such as Neos and Mediterranean Formula, collaborates with universities and research institutions, and reports research in peer‑reviewed journals.
Koye Wellness GmbH
Hergiswil Nw · Since 2019
Kyowa Kirin Sàrl
Geneva · Since 2016
The core activity of Krystal Biotech, Inc. is the development and manufacture of pharmaceuticals, particularly biopharmaceuticals. The company focuses on the research and development of new therapeutics based on genetic and biotechnological methods. The company's products aim to treat various diseases and conditions, including rare genetic disorders.
Lallemand Pharma AG
Massagno · Since 2007
The core activity of Lallemand Pharma is the development and marketing of respiratory products classified as medicinal products or medical devices. In particular, the company focuses on the manufacture of immunostimulant drugs and medical devices based on bacterial lysates such as PMBL.
LAM Biotechnologies SA
Epalinges · Since 2018
Windward Bio Group AG
Basel · Since 2024
Leopard Sight Mordiva Life Sciences
Binningen · Since 2020
The core activity of LSM Life Sciences is the conduct of clinical trials and research projects in the healthcare sector, particularly in Sub-Saharan Africa. The company acts as a Contract Research Organization (CRO) and offers services such as project management, study planning, data management, laboratory management and consulting for the conduct of clinical trials. The goal is to improve healthcare in Africa by bringing together local and global partners to strengthen healthcare capacities.
Life Episteme Group Sàrl
Geneva · Since 2013
LifeMine Therapeutics (Switzerland) GmbH
Basel · Since 2022
The core activity of LifeMine Therapeutics is the development of precision medical therapies, particularly the research and development of drugs that act at the genetic level. The company focuses on the discovery and development of new active substances that target specific genetic targets to combat diseases.
Lonza AG
Visp
Luzsana Biotechnology Europe AG
Basel · Since 2020
The core activity of Luzsana Biotechnology Europe AG is the development and marketing of innovative medicines, particularly in the field of biotechnology. The company focuses on conducting clinical trials and global distribution of medicines to make them accessible to patients worldwide.
Lyron AG
Basel · Since 1986
MABXIENCE SA
Lugano · Since 2012
The company's core activity is the development, manufacture and marketing of biopharmaceutical products, including active pharmaceutical ingredients (APIs), vaccines and finished dosage forms (FDFs), as well as the production of biotechnological medicines for the manufacture of monoclonal antibodies and vaccines.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register